GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $95.46.

A number of analysts have weighed in on the stock. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their price target for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective on the stock. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research report on Thursday, October 31st. Finally, Evercore ISI upped their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an "outperform" rating in a research report on Tuesday, October 1st.

GE HealthCare Technologies Stock Up 0.8 %

NASDAQ:GEHC traded up $0.66 during trading hours on Monday, hitting $81.90. The company's stock had a trading volume of 2,372,177 shares, compared to its average volume of 3,129,239. GE HealthCare Technologies has a 52-week low of $67.00 and a 52-week high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $37.42 billion, a P/E ratio of 22.32, a price-to-earnings-growth ratio of 2.91 and a beta of 1.08. The stock has a fifty day moving average of $86.80 and a 200-day moving average of $83.68.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business's revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.99 EPS. On average, equities analysts forecast that GE HealthCare Technologies will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies's payout ratio is currently 3.30%.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.27% of the company's stock.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors have recently modified their holdings of GEHC. CWM LLC boosted its position in shares of GE HealthCare Technologies by 2.3% during the 2nd quarter. CWM LLC now owns 10,655 shares of the company's stock worth $830,000 after purchasing an additional 239 shares in the last quarter. QRG Capital Management Inc. boosted its holdings in GE HealthCare Technologies by 5.9% during the second quarter. QRG Capital Management Inc. now owns 6,643 shares of the company's stock worth $518,000 after buying an additional 370 shares in the last quarter. Czech National Bank grew its position in GE HealthCare Technologies by 8.5% during the second quarter. Czech National Bank now owns 80,879 shares of the company's stock worth $6,302,000 after buying an additional 6,367 shares during the period. Sequoia Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 1.9% in the second quarter. Sequoia Financial Advisors LLC now owns 9,276 shares of the company's stock valued at $723,000 after buying an additional 174 shares in the last quarter. Finally, WASHINGTON TRUST Co lifted its position in shares of GE HealthCare Technologies by 23.7% during the 2nd quarter. WASHINGTON TRUST Co now owns 2,293 shares of the company's stock valued at $179,000 after acquiring an additional 440 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.